Indian Pharma is down in the dumps and does not see any hope for a turnaround around any time soon. However, analyzing the Pharma companies namely we were intrigued to see the valuations from a price to book perspective. Seeing a price to book ratio in FY 19 of around 2 for companies like Dr Reddy’s, Aurobindo Pharma, Lupin, Cipla and Glenmark make it interesting at some time in the future. Continue reading “Indian Pharma Stocks: Cheap or Not”
Buying your first mutual fund should be profitable, simple and straightforward. Being profitable is very important as buying a mutual fund entails costs and we would want to buy a mutual funds where they costs are minimum so that our profits are maximized. Most of us buy mutual funds from a distributor and a distributor always charges a commission and we don’t even know about it. We will discuss a DIY – do it yourself way to buy mutual funds with incurring costs. Continue reading “Buying your first mutual fund – Direct mutual funds”
We are taught various subjects in school with the glaring exception of money, finance, investing. We all want to be wealthy but no one teaches us how to be wealthy. For the average person becoming wealthy will take time and effort. For most becoming wealthy seems such an impossible dream that the don’t even plan for. The solution for this is to think big and start small and keep building on it, a step at a time. Continue reading “Investing beginners wanting to be wealthy, start with Index Mutual Funds”
As FY-18 comes to an end the market has seen a large number of wind auctions from SECI and the states of Gujarat, Tamil Nadu and Maharshtra. While the falling rates are creating pressure for all including the wind turbine suppliers. However, Indian OEM’s namely Inox Wind and Suzlon appear to be winning. Continue reading “Wind Turbine OEM Winners: SECI & State Auctions”
A weak set of numbers for Q2-18 were not a surprise given the pricing discovered in the auctions. However, the quantity and quality of disclosures made in the investor presentations was even more disappointing. The company managing to stay in the black in H2-18 by the magical appearance of a gain of Rs 455 crore on derecognition of asset and liability and release of foreign currency translation gain on account of overseas business subsidiary. We don’t understand what this non cash gain means. It seems as if this was a magic track up its sleeve held back for a poor quarter. All said and done, on paper Suzlon clocks in another profitable quarter. Continue reading “Suzlon: Q2-18 disappoints as expected”
Patanjali Ayurveda is the most talked about FMCG company in India, giving stiff competition to established players like HUL, Colgate, Nestle etc. However, Patanjali Ayurveda is not listed in the stock market and does not provide an opportunity to for the retail investor. We have been keenly watching the collaboration between Patanjali Ayurveda and Ruchi Soya since the start of 2017 and are wondering if Ruchi Soya could be vehicle to ride the Patanjali phenomenon. Continue reading “Ruchi Soya: A vehicle to ride on the Patanjali Phenomenon”
Suzlon looks much stronger from a year back when we initiated coverage given four consecutive quarters of profitability. However, the strength of the company does reflect itself in its stock price performance. A Suzlon stock holder has not made any money in the last 1 year. Continue reading “Suzlon: A good Q1 in a FY18 which is expected to be tough”
Suzlon has given two consecutive years with a positive PAT. A positive PAT for FY-16 was delivered on the back of Senvion sale and not based on operational performance. FY-17 PAT was delivered based on strong operational performance and strong market share gains. We are reasonably comfortable with our initial thesis from a year ago as Suzlon delivered a strong FY-17. (Refer Suzlon: Not for the faint hearted and impatient investor)
We continue to be optimistic as we look towards FY-18 Continue reading “Suzlon: Good Q4-17; Strong FY-17; Optimistic for FY-18”
We got interested in the stock during the volatility seen in the Yes Bank stock during its failed QIP in Sep-16 (Yes Bank: Say Yes). Time flies and we are reviewing our position in the Yes Bank stock with the price up by 30%+. We are looking at market volatility in the stock price to add to our positions in the stock. Continue reading “Yes Bank: Still Say Yes”
We had looked at Apollo Tyres nearly a year back (Apollo Tyres: Available at attractive valuations) and our view was framed based the thesis of lower commodity prices namely lower rubber and crude prices. Our thesis has played out and the price is has moved around 50% higher from the time we started looking at Apollo Tyres. However, the 16% drop in the Q4-17, PAT made us re-look at our position. Apollo Tyres has moved from being available at attractive valuations to now being available at reasonable valuations. Continue reading “Apollo Tyres: Capex not yet priced in”
Indian Pharma along with Indian IT is the most unloved sector when the market is near its all time high with the Nifty at 9,000+. We get interested in well run companies when they re available at attractive prices. The prices could be attractive from a PE multiple or attractive from a psychological level i.e. close to their 52 week lows. We found some interesting names and are looking at them as portfolio after investing the company specific issues. Continue reading “Indian Pharma : Time to swallow a bitter pill”
SoEvery profitable quarter for Suzlon adds to our comfort in the outlook and the turnaround story at play. While we are comforted by a profitable quarter, we also observe certain issues which indicate the outlook and turnaround story is not as rosy as Suzlon would want us to believe. Continue reading “Suzlon: A profitable Q3-17 comforts; does not support a stock price break out”
A key part of the thesis in favor of Tata Motors was the expectation of the JLR franchise gaining market share.
JLR to gain market share in the luxury market given its success in taking both the brands global i.e. China, US and Europe.
We feel better now that we have seen the JLR franchise gaining market share. Continue reading “Tata Motors: Market Share Gains Delivered”
Looking at the news released by Suzlon related to order flow does not inspire significant confidence in the prospects of a strong performance for Q3-17.
The quarterly order flow is indicating that volatility in the recovery of Suzlon as Q3-17 is expected to be a weak quarter.
List of orders in 2016
We expect the stock price to react to the weak Q3-17.
- Suzlon: Not for the faint hearted and impatient investor
- Suzlon: Q1-17 is not good
- Suzlon: Q2-17 looks better; but not enough to rerate the stock price
Suzlon which is trying to come back on the path on profitability delivered a setback as it started the first quarter of FY17 in the red and jumped into profitability in Q2-17 and hence ending H1-17 with a marginal loss. A negative PAT (profit after tax) does not concern us significantly as we never expected a straight line path to recovery.(Refer: Suzlon: Not for the faint hearted and impatient investor and Suzlon: Q1-17 is not good) What concerned us is that the growth outlook for the wind business though improving from Q1-17, still does not give us the full confidence. Continue reading “Suzlon: Q2-17 looks better; but not enough to rerate the stock price”
Suzlon which is trying to come back on the path on profitability delivered a setback as it started the first quarter of FY17 in the red. A negative PAT (profit after tax) does not concern us significantly as we never expected a straight line path to recovery.(Refer: Suzlon: Not for the faint hearted and impatient investor) What concerned us is that Suzlon management is trying to make the Q1-FY17 performance look stronger than it is. Continue reading “Suzlon: Q1-17 is not good”
Yes Bank is one of the leading new age private banks and which got in the new with the failed $1 billion QIP (Qualified Institutional Placement). The stock responded negatively to failed QIP with a close to 8% haircut and fear of a temporary overhang on the stock. The failed QIP without any changes in the underlying business could provide an opportunity to enter the stock while living with the risk of temporary overhang on the stock on account of the failed QIP. The failed QIP could lead to bigger cuts in the stock price. Continue reading “Yes Bank: Say Yes”
InterGlobe Aviation more commonly recognized as IndiGo is the largest domestic airline with a market share of more than 35%. IndiGo is one of the most successful Indian low cast carrier which has taken market share from its competitors. IndiGo has increased its market share from around 12% in 2009 to the current market share of 35% with a possibility of the market share moving closer to 40% by the end of the financial year.
Camlin Fine Sciences is a leading specialty chemicals manufacturer in the Diphenol downstream segment. Camlin Fine Sciences is the biggest global manufacturer of antioxidants, namely Tert‐Butyl Hydroquinone (TBHQ) and Butylated Hydroxyanisole (BHA). It is currently undergoing a transformation via capacity expansion to further solidify its leading market share, improve cost competitiveness and focus on value added products.
Tata Motors through its global Jaguar Land Rover (JLR) franchise is a small yet growing player in the global luxury car (Jaguar) and SUV market (Land Rover). In the India market, it is a leading player in the in the commercial vehicle (CV) market and a very small player in the passenger vehicle (PV) market. Tata Motors is a tale of two cities when one compares the performance of the global JLR franchise with the India business. Continue reading “Tata Motors: Not Fantastico yet”
NMDC is the largest iron ore produce of India. In FY16, NMDC produced ~28.32 million tonnes of iron ore out of the 155 million tonnes produced in India from its mines in Chhattisgarh and Karnataka. NMDC is currently working towards commissioning a steel plant at Nagarnar, Chhattisgarh by Dec-17 that will produce around 3 million tonnes of flat products. NMDC will maintain its position as the largest producer of iron ore in the country in FY17. Continue reading “NMDC: Too expensive to be a value buy”
Inox Wind is a leading wind turbine manufacturer and is a part of the larger Inox Group. Inox Wind initially depended on in-house orders from the larger group but has since evolved into a serious player in the industry. However, the price of the stock has halved from the listing price of its IPO in April 2015. Continue reading “Inox Wind: Trying to catch a falling knife”
Suzlon was the largest wind turbine generator (WTG) manufacturer in India who aspired to be a dominant global player. The company took on large amount of debt to acquire a position for itself the global wind turbine market. Continue reading “Suzlon: Not for the faint hearted and impatient investor”
The India consumption story is broken into rural and urban consumption. The employment opportunities generated in the IT industry are a driver of the urban middle class India consumption story. The employment opportunities generated in the India IT sector are on a path of secular decline. How would this impact real estate, consumer discretionary, autos built up on the urban India consumption story? Continue reading “Threat to the urban India consumption story”
Apollo Tyres is the second largest tyre manufacturer and sells its products under the Apollo and Vredestein brands. The truck and bus segment accounts for around half of its sales. The passenger car and light trucks segments account for around a third of its sales. These two segments contribute to close to 85% of its sales. Around three fourths of its revenues are from the replacement market. Outside of the domestic market, Europe contributes around a fourth of its revenues. Opportunities in the European could drive the unfolding of the Apollo Tyre story in the next 12 to 18 months. Continue reading “Apollo Tyres: Available at attractive valuations”
We have a very simple approach to investing stocks. In our simple approach to investing in stocks we have one like and one dislike. We LIKE to make a lot of money. We DISLIKE losing money. We are quite patient and in no hurry to make lots of money. So we invest in the long term without worrying about the short term prices. So this is how we do it. Continue reading “How to identify stocks to invest in?”
While many of us are familiar with Zicom Electronic Security Systems Limited as a leading Electronic Security Surveillance company in India, in reality it should be seen as provider of fire monitoring solutions in the Middle East. Around 60% of its revenue comes from fire monitoring solutions while only around 30% percent comes from CCTV-camera surveillance security. On the security side of the business the hardware business is dominant. Continue reading “Zicom: A security & fire solutions provider available for cheap in increasingly insecure times”
Zydus Wellness has strong market share in niche health and wellness categories of the FMCG market and could be considered as buy in your portfolio. Its portfolio of brands include:
- Sugar Free – sugar substitute
- Nutralite – butter substitute
- EverYuth – skin care products
- Actilife – health drink
If you are not an investor then it may be a waste of time, spending your time out here. So before you enter this place please take a step back and reassure yourself that you are an investor for sure. Continue reading “Are you an investor?”